Report cover image

Global Antidepressants Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 191 Pages
SKU # APRC20361481

Description

Summary

According to APO Research, The global Antidepressants market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antidepressants is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antidepressants is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Antidepressants is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Antidepressants is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antidepressants include Bristol-Myers Squibb Company, H Lundbeck, Sun Pharmaceuticals, Astrazeneca, GlaxoSmithKline, Pfizer Inc., Eli Lilly and Company, Merck and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antidepressants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Antidepressants, also provides the sales of main regions and countries. Of the upcoming market potential for Antidepressants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antidepressants sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Antidepressants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Antidepressants sales, projected growth trends, production technology, application and end-user industry.

Antidepressants Segment by Company

Bristol-Myers Squibb Company
H Lundbeck
Sun Pharmaceuticals
Astrazeneca
GlaxoSmithKline
Pfizer Inc.
Eli Lilly and Company
Merck
Johnson & Johnson
Sanofi
Antidepressants Segment by Type

Benzodiazepines
Monoamine Oxidase Inhibitors
Antipsychotics
Tricyclic Antidepressants
Novel Agents
Selective Norepinephrine Reuptake Inhibitors
Selective Serotonin Reuptake Inhibitors
Antidepressants Segment by Application

Hospitals
Clinics
Other
Antidepressants Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidepressants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antidepressants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidepressants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Antidepressants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Antidepressants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antidepressants sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Antidepressants Market by Type
1.2.1 Global Antidepressants Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Benzodiazepines
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Antipsychotics
1.2.5 Tricyclic Antidepressants
1.2.6 Novel Agents
1.2.7 Selective Norepinephrine Reuptake Inhibitors
1.2.8 Selective Serotonin Reuptake Inhibitors
1.3 Antidepressants Market by Application
1.3.1 Global Antidepressants Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Antidepressants Market Dynamics
2.1 Antidepressants Industry Trends
2.2 Antidepressants Industry Drivers
2.3 Antidepressants Industry Opportunities and Challenges
2.4 Antidepressants Industry Restraints
3 Global Market Growth Prospects
3.1 Global Antidepressants Revenue Estimates and Forecasts (2020-2031)
3.2 Global Antidepressants Revenue by Region
3.2.1 Global Antidepressants Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Antidepressants Revenue by Region (2020-2025)
3.2.3 Global Antidepressants Revenue by Region (2026-2031)
3.2.4 Global Antidepressants Revenue Market Share by Region (2020-2031)
3.3 Global Antidepressants Sales Estimates and Forecasts 2020-2031
3.4 Global Antidepressants Sales by Region
3.4.1 Global Antidepressants Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Antidepressants Sales by Region (2020-2025)
3.4.3 Global Antidepressants Sales by Region (2026-2031)
3.4.4 Global Antidepressants Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Antidepressants Revenue by Manufacturers
4.1.1 Global Antidepressants Revenue by Manufacturers (2020-2025)
4.1.2 Global Antidepressants Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Antidepressants Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Antidepressants Sales by Manufacturers
4.2.1 Global Antidepressants Sales by Manufacturers (2020-2025)
4.2.2 Global Antidepressants Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Antidepressants Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Antidepressants Sales Price by Manufacturers (2020-2025)
4.4 Global Antidepressants Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Antidepressants Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Antidepressants Manufacturers, Product Type & Application
4.7 Global Antidepressants Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Antidepressants Market CR5 and HHI
4.8.2 2024 Antidepressants Tier 1, Tier 2, and Tier 3
5 Antidepressants Market by Type
5.1 Global Antidepressants Revenue by Type
5.1.1 Global Antidepressants Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Antidepressants Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Antidepressants Revenue Market Share by Type (2020-2031)
5.2 Global Antidepressants Sales by Type
5.2.1 Global Antidepressants Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Antidepressants Sales by Type (2020-2031) & (W Units)
5.2.3 Global Antidepressants Sales Market Share by Type (2020-2031)
5.3 Global Antidepressants Price by Type
6 Antidepressants Market by Application
6.1 Global Antidepressants Revenue by Application
6.1.1 Global Antidepressants Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Antidepressants Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Antidepressants Revenue Market Share by Application (2020-2031)
6.2 Global Antidepressants Sales by Application
6.2.1 Global Antidepressants Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Antidepressants Sales by Application (2020-2031) & (W Units)
6.2.3 Global Antidepressants Sales Market Share by Application (2020-2031)
6.3 Global Antidepressants Price by Application
7 Company Profiles
7.1 Bristol-Myers Squibb Company
7.1.1 Bristol-Myers Squibb Company Comapny Information
7.1.2 Bristol-Myers Squibb Company Business Overview
7.1.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Bristol-Myers Squibb Company Antidepressants Product Portfolio
7.1.5 Bristol-Myers Squibb Company Recent Developments
7.2 H Lundbeck
7.2.1 H Lundbeck Comapny Information
7.2.2 H Lundbeck Business Overview
7.2.3 H Lundbeck Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 H Lundbeck Antidepressants Product Portfolio
7.2.5 H Lundbeck Recent Developments
7.3 Sun Pharmaceuticals
7.3.1 Sun Pharmaceuticals Comapny Information
7.3.2 Sun Pharmaceuticals Business Overview
7.3.3 Sun Pharmaceuticals Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Sun Pharmaceuticals Antidepressants Product Portfolio
7.3.5 Sun Pharmaceuticals Recent Developments
7.4 Astrazeneca
7.4.1 Astrazeneca Comapny Information
7.4.2 Astrazeneca Business Overview
7.4.3 Astrazeneca Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Astrazeneca Antidepressants Product Portfolio
7.4.5 Astrazeneca Recent Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Comapny Information
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 GlaxoSmithKline Antidepressants Product Portfolio
7.5.5 GlaxoSmithKline Recent Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Comapny Information
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Pfizer Inc. Antidepressants Product Portfolio
7.6.5 Pfizer Inc. Recent Developments
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Comapny Information
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Eli Lilly and Company Antidepressants Product Portfolio
7.7.5 Eli Lilly and Company Recent Developments
7.8 Merck
7.8.1 Merck Comapny Information
7.8.2 Merck Business Overview
7.8.3 Merck Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Merck Antidepressants Product Portfolio
7.8.5 Merck Recent Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Comapny Information
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Johnson & Johnson Antidepressants Product Portfolio
7.9.5 Johnson & Johnson Recent Developments
7.10 Sanofi
7.10.1 Sanofi Comapny Information
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Sanofi Antidepressants Product Portfolio
7.10.5 Sanofi Recent Developments
8 North America
8.1 North America Antidepressants Market Size by Type
8.1.1 North America Antidepressants Revenue by Type (2020-2031)
8.1.2 North America Antidepressants Sales by Type (2020-2031)
8.1.3 North America Antidepressants Price by Type (2020-2031)
8.2 North America Antidepressants Market Size by Application
8.2.1 North America Antidepressants Revenue by Application (2020-2031)
8.2.2 North America Antidepressants Sales by Application (2020-2031)
8.2.3 North America Antidepressants Price by Application (2020-2031)
8.3 North America Antidepressants Market Size by Country
8.3.1 North America Antidepressants Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Antidepressants Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Antidepressants Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Antidepressants Market Size by Type
9.1.1 Europe Antidepressants Revenue by Type (2020-2031)
9.1.2 Europe Antidepressants Sales by Type (2020-2031)
9.1.3 Europe Antidepressants Price by Type (2020-2031)
9.2 Europe Antidepressants Market Size by Application
9.2.1 Europe Antidepressants Revenue by Application (2020-2031)
9.2.2 Europe Antidepressants Sales by Application (2020-2031)
9.2.3 Europe Antidepressants Price by Application (2020-2031)
9.3 Europe Antidepressants Market Size by Country
9.3.1 Europe Antidepressants Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Antidepressants Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Antidepressants Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
9.3.9 Nordic Countries
10 China
10.1 China Antidepressants Market Size by Type
10.1.1 China Antidepressants Revenue by Type (2020-2031)
10.1.2 China Antidepressants Sales by Type (2020-2031)
10.1.3 China Antidepressants Price by Type (2020-2031)
10.2 China Antidepressants Market Size by Application
10.2.1 China Antidepressants Revenue by Application (2020-2031)
10.2.2 China Antidepressants Sales by Application (2020-2031)
10.2.3 China Antidepressants Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Antidepressants Market Size by Type
11.1.1 Asia Antidepressants Revenue by Type (2020-2031)
11.1.2 Asia Antidepressants Sales by Type (2020-2031)
11.1.3 Asia Antidepressants Price by Type (2020-2031)
11.2 Asia Antidepressants Market Size by Application
11.2.1 Asia Antidepressants Revenue by Application (2020-2031)
11.2.2 Asia Antidepressants Sales by Application (2020-2031)
11.2.3 Asia Antidepressants Price by Application (2020-2031)
11.3 Asia Antidepressants Market Size by Country
11.3.1 Asia Antidepressants Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Antidepressants Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Antidepressants Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Antidepressants Market Size by Type
12.1.1 SAMEA Antidepressants Revenue by Type (2020-2031)
12.1.2 SAMEA Antidepressants Sales by Type (2020-2031)
12.1.3 SAMEA Antidepressants Price by Type (2020-2031)
12.2 SAMEA Antidepressants Market Size by Application
12.2.1 SAMEA Antidepressants Revenue by Application (2020-2031)
12.2.2 SAMEA Antidepressants Sales by Application (2020-2031)
12.2.3 SAMEA Antidepressants Price by Application (2020-2031)
12.3 SAMEA Antidepressants Market Size by Country
12.3.1 SAMEA Antidepressants Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Antidepressants Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Antidepressants Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Antidepressants Value Chain Analysis
13.1.1 Antidepressants Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Antidepressants Production Mode & Process
13.2 Antidepressants Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Antidepressants Distributors
13.2.3 Antidepressants Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.